Medical Group Member
Yasser A. Khaled, MD - Hematology & Oncology
Hematology and Oncology, Cancer - Blood Conditions (Hematology), Oncology and Hematology
Orlando Health Cancer Institute - Downtown Orlando
Address: 1400 S. Orange Ave.
Orlando, FL 32806
Call: (321) 841-1869
Fax: (321) 843-6285
Bio
Dr. Yasser Khaled is the medical director of the bone marrow transplant and cellular therapy program at the Orlando Health Cancer Institute. He is board-certified in hematology and specializes in cellular therapy and blood and bone marrow transplantation. His areas of expertise include:
- Bone marrow transplants (autologous, allogeneic, cord blood and haploidentical)
- Bispecific antibodies
- CAR-T cell therapy
- Acute leukemia/myelodysplastic syndrome treatment
- Cellular therapy lab (on-site collection facility and cell manipulation)
- Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma, graft versus host disease and lung transplant rejection
- Clinical trials
Dr. Khaled’s Training
Dr. Khaled received his medical training at Cairo University School of Medicine in Egypt. He completed a residency in internal medicine at Woodhull Medical Center in New York. Dr. Khaled also completed fellowships in medical oncology at Virginia Commonwealth University in Richmond, in hematology at New York Medical College in Valhalla and in blood and bone marrow transplantation at the University of Texas / MD Anderson Cancer Center in Houston.
About Dr. Khaled
Dr. Khaled is board-certified in hematology by the American Board of Internal Medicine.
Before joining Orlando Health, Dr. Khaled served as medical director of the Blood and Marrow Transplant Center at Methodist Le Bonheur Health Care in Memphis. In less than four years, he led the program to a top 10 percent ranking in survival outcomes, according to the National Marrow Donor Program, an independent agency that reviews the outcomes of bone marrow transplant centers in the United States. He also brought the first cellular immune therapy (CAR-T cell) for the treatment of lymphoma and acute leukemia to Memphis and the Mid-South, an achievement that earned him an award as a Memphis Health Care Hero in 2019.
Dr. Khaled has an established research career in stem cell transplantation as principal investigator and co-investigator for multiple industry- and NIH-funded protocols. He also has published extensively in the field of stem cell transplantation with dozens of articles and abstracts.
Board Certifications
Academic Information
Medical Education
University of CairoResidency
Woodhull Medical and Mental Health CenterFellowship
The University of Texas/MD Anderson Cancer Center
Notice
Closed
Impacted
Coming Soon
This is a comprehensive list of insurances accepted at Orlando Health hospitals, outpatient services and physician groups. Be sure to contact your individual insurer to verify coverage. Not all providers accept the same insurance. If possible, check with your providers prior to your procedure or appointment to verify coverage.
How Bone Marrow Transplants Save Lives
Why do some Orlando Health physicians not have a patient experience rating?
The Patient Satisfaction Rating is an average of all responses to the care provider related questions, shown above, from our nationally-recognized Press-Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5, with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Orlando Health.
Ratings may not be present for certain physicians of Orlando Health Physician Group and Orlando Health Physician Associates because:
- The physician has not yet met the minimum number of 30 patient satisfaction surveys to be eligible for display.
- They may be a researcher or type of provider that does not see patients.
- They may practice in a specialty or office that has not yet implemented the specified surveys used for these ratings.
- English
- Spanish
- English (CC)
